The chemical class termed TMEM161B Activators encompasses a diverse array of compounds with the capacity to modulate the activity of the TMEM161B protein, which is a transmembrane protein. These activators can influence the protein's function through a variety of mechanisms, primarily by engaging and modifying signaling pathways that have downstream effects on TMEM161B activity. By altering the levels of intracellular molecules such as cAMP or calcium, these activators can induce conformational changes or post-translational modifications in TMEM161B, which can lead to changes in its activity state. Some activators within this class function by inhibiting or activating specific kinases or phosphatases, thereby influencing the phosphorylation status of proteins, including TMEM161B. Others may act by binding directly or indirectly to TMEM161B or related signaling partners, thereby changing the functional dynamics of the protein.
Activators in this chemical class can also exert their effects by altering the lipid environment of the cell membrane, which in turn can affect the behavior of transmembrane proteins like TMEM161B. Modulation of enzyme activity that affects phospholipid metabolism, for instance, can lead to changes in membrane fluidity and signaling lipid domains, which can enable or enhance the activation of TMEM161B. Additionally, these compounds can impact the interaction of TMEM161B with other cellular proteins, altering its localization, stability, or involvement in complex signaling assemblies. The diverse mechanisms by which these activators operate are unified by their common outcome: the modulation of TMEM161B activity, which is pivotal for the protein's role in cellular processes. These activators thus represent a crucial toolset for dissecting the biological functions of TMEM161B and for manipulating its activity in a controlled experimental context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Adenylyl cyclase activator, increases intracellular cAMP levels, which could possibly activate TMEM161B by modulating PKA and associated cellular functions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which could possibly activate TMEM161B through phosphorylation and modulation of its activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Calcium ionophore that raises intracellular calcium levels and could possibly activate TMEM161B by affecting calcium-sensitive pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor that could possibly activate TMEM161B by altering signaling pathways and protein interactions. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
A cell-permeable cAMP analog that could possibly activate TMEM161B by engaging cAMP-dependent pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that could possibly activate TMEM161B by interfering with the MAPK/ERK pathway. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
RAF kinase inhibitor that could possibly activate TMEM161B by altering downstream signaling mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAP kinase inhibitor that could possibly activate TMEM161B by influencing related signaling pathways. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Calmodulin antagonist that could possibly activate TMEM161B by affecting calcium-signaling pathways. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) which could possibly activate TMEM161B by modulating signaling pathways. | ||||||